Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Parnax Lab Ltd

NSE: PARNAXLAB · BSE: 506128 · Pharmaceuticals & Biotechnology · 20 announcements

Share price
₹112.00
Market cap
₹128.6 Cr
Revenue (annual)
₹248.5 Cr
Net profit (annual)
₹11.78 Cr
P/E (TTM)
14.4×Sector 47.4×
Promoter holding
72.30%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:24 IST BSE
Annual General Meeting

Parnax Lab Annual General Meeting

Parnax Lab Ltd announced its 44th Annual General Meeting scheduled for September 29, 2026, through video conferencing. The agenda includes appointing statutory auditors and related party transactions.

17:05 IST BSE
Annual Report

Parnax Lab Annual Report

Parnax Lab Ltd has submitted its 44th Annual Report for the financial year 2025-2026. The 44th AGM is scheduled for September 29, 2026.

16:58 IST BSE
Annual General Meeting

Parnax Lab Annual General Meeting

Parnax Lab Ltd has announced the closure of its register of members and share transfer books from 23rd to 29th September 2026 for its 44th AGM.

16:54 IST BSE
Board Meeting Outcome

Parnax Lab Board Meeting Outcome

Parnax Lab Ltd approved the revised Directors' Report and took note of the Secretarial Auditors' Report for the financial year ended March 31, 2026.

10:40 IST BSE
Promoter Buying (Off-Market)

Parnax Lab Promoter Buying (Off-Market)

Mihir Prakash Shah, a promoter of Parnax Lab Limited, acquired 3,77,355 equity shares (3.28% stake) via an inter-se gift from another promoter, Baiju Shah.

16:26 IST BSE
Management Change

Parnax Lab Management Change

Parnax Lab Limited has re-appointed Mr. Yogesh Kantilal Varia as a Non-Executive Independent Director for a term of 60 months.

16:19 IST BSE
Annual General Meeting

Parnax Lab Annual General Meeting

Parnax Lab shareholders approved the re-appointment of Mr. Yogesh Kantilal Varia as a Non-Executive & Independent Director for a second five-year term.